What Clinical Evidence Shows About GLP-1s and Fetal Development Preclinical studies in animals exposed to semaglutide at doses higher than therapeutic human levels revealed delays in fetal skeletal development and changes in cardiac morphology
The dose-dependent glycemic benefit is well-characterized across the clinical trial program
Availability, approval status, and timeline The single biggest practical difference between Ozempic and retatrutide right now has nothing to do with efficacy or safety
Its a supplement-only option with no medical oversight, not approved by the FDA
But from deep concern about how quickly weight-loss medication is being normalised without enough conversation about metabolism, gut health and long-term healing
Walking on an incline, cycling, elliptical, swimming